Leith Wheeler Investment Counsel’s AstraZeneca AZN Stock Holding History

Leith Wheeler Investment Counsel’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61,319	Closed	-$8.31M	–	58
2023 Q3	$8.31M	Buy	61,319 +20,914	+52%	+$2.86M	1.1%	21
2023 Q2	$5.78M	Buy	40,405 +3,325	+9%	+$489K	0.76%	35
2023 Q1	$5.15M	Buy	37,080 +2,375	+7%	+$320K	0.76%	33
2022 Q4	$4.71M	Buy	34,705 +3,250	+10%	+$408K	0.71%	32
2022 Q3	$3.45M	Buy	31,455 +12,275	+64%	+$1.56M	0.58%	30
2022 Q2	$3.26M	Buy	19,180 +7,763	+68%	+$1.02M	0.43%	29
2022 Q1	$1.51M	Buy	+11,417	New	+$1.37M	0.23%	31

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Leith Wheeler Investment Counsel's AZN Position: Q4 2023 in Review

Leith Wheeler Investment Counsel sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 61,319 shares — an estimated $8.31M sold.

Leith Wheeler Investment Counsel first reported a position in AZN in Q1 2022 and held it in 7 quarters. The position peaked at $8.31M in Q3 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

Leith Wheeler Investment Counsel reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
Leith Wheeler Investment Counsel sold 61,319 AstraZeneca shares in Q4 2023, an estimated $8.31M.
Leith Wheeler Investment Counsel first reported a position in AstraZeneca in Q1 2022 and held it in 7 quarters.
Leith Wheeler Investment Counsel's AstraZeneca position peaked at $8.31M in Q3 2023.
1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Leith Wheeler Investment Counsel's 13F filing for Q4 2023, filed 8 Jan 2024.